Developer docs
API playgroundTry for free, no card

Search company profiles

American Association for Cancer Research

Full company profile

uuid0006td5

Namestring
American Association for Cancer Research
Legal namestring
American Association for Cancer Research
Websiteurl
aacr.org
Company typeenum
Private
Founded yearint
1907
Descriptiontext

The American Association for Cancer Research (AACR) is a 501(c)(3) nonprofit professional membership organization founded in 1907 and headquartered in Philadelphia, Pennsylvania. It is the first and largest professional organization dedicated to preventing and curing cancer through research, education, communication, and collaboration, and it currently serves more than 65,000 members worldwide, including cancer researchers, clinicians, healthcare professionals, and patient advocates. Its mission is operationalized through publications, scientific meetings, research grants, and policy advocacy.

AACR's product and technology footprint centers on a portfolio of ten peer-reviewed scientific journals (including Cancer Discovery, Cancer Research, Clinical Cancer Research, and Blood Cancer Discovery); the AACR Annual Meeting, which drew more than 22,000 attendees from over 140 countries in its 2026 edition; three annual Cancer Progress Reports covering overall, disparities, and pediatric cancer; Project GENIE, a publicly accessible international cancer registry aggregating real-world data from leading cancer centers; the Scientist↔Survivor Program connecting patient advocates with researchers; the AACR Cancer Centers Alliance of 94 member centers; and a grants program that administers fellowships, career awards, and the $15 million Trailblazer Cancer Research Grants.

AACR's business model is a diversified nonprofit funding stack: recurring annual membership dues from 65,000+ members, subscription and licensing revenue from ten scientific journals, registration fees from the Annual Meeting and specialized conferences, foundation-level philanthropic income through the AACR Foundation, and grants and donations from corporate and institutional partners such as AWS, Pfizer, Mark Foundation, Lustgarten Foundation, and Debbie's Dream Foundation. Distribution is anchored by direct member engagement, flagship and specialized conferences, peer-reviewed journals, and the Project GENIE data registry. The organization does not monetize software products, SaaS platforms, or AI model APIs.

Short descriptiontext

The American Association for Cancer Research (AACR) is a Philadelphia-based 501(c)(3) nonprofit membership organization founded in 1907 that serves over 65,000 cancer researchers, clinicians, and patient advocates worldwide through scientific journals, the AACR Annual Meeting, research grants, policy advocacy, and Project GENIE.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersPhiladelphia, United States
HQ citystring
Philadelphia
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer research membership, scientific journal publishing, research conference hosting, cancer research grants, professional medical society
Industry1 code
1Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
CodeBPAGACAAPrimaryYes
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Business Associations813910
SIC code2 codes
  • Services-Membership Organizations8600
  • Services-Health Services8000
Product category
Professional Cancer Research Association
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Membership Dues
TypeSubscription Recurring
Description

Annual membership fees from over 65,000 members worldwide including researchers, clinicians, and patient advocates

aacr.org
2Publications and Journals
TypeSubscription Recurring
Description

Revenue from scientific journal subscriptions and publications including Cancer Today magazine

aacr.org
3Conference and Meeting Fees
TypeSubscription Recurring
Description

Registration fees from Annual Meeting and specialized conferences throughout the year

aacr.org
4Research Grants and Donations
TypeLicensing Royalties
Description

Grants such as the $150,000 AWS Imagine Grant for Project GENIE, plus individual and corporate donations through AACR Foundation

aacr.org
5AACR Foundation Philanthropy
TypeAffiliate Referral
Description

Donations, planned giving, workplace giving, and corporate partnerships supporting cancer research

aacr.org
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Others, Marketing or Sales, Technology or R&D
Pricing details2 tiers
1Reduced registration for patient advocates
ModelSubscriptionBilling cadenceOne time
Notes

AACR offers discounted registration rates for patient advocates in recognition of the essential perspective they bring to the scientific discussion. Patient Advocate Registration Scholarships are also available in limited numbers.

aacr.org
2Membership categories
ModelSubscriptionBilling cadenceAnnual
Notes

Various membership categories including associate member, full member, and student membership with associated benefits

aacr.org
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

AACR is a nonprofit professional membership organization that advances cancer research through membership services, a portfolio of ten peer-reviewed scientific journals, the premier global AACR Annual Meeting, specialized conferences and educational workshops, research grants and fellowships, the Project GENIE international cancer data registry, and policy advocacy. It serves more than 65,000 members worldwide, including cancer researchers, clinicians, and patient advocates, while connecting cancer centers through the AACR Cancer Centers Alliance of 94 member institutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 34% decrease in overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
+4 more records
Product overview1 text field

The American Association for Cancer Research (AACR) operates as a nonprofit membership organization rather than a technology product company. Its core offerings include a portfolio of 10 peer-reviewed scientific journals (Cancer Research, Cancer Discovery, Clinical Cancer Research, etc.), the AACR Annual Meeting as the premier cancer research conference, and three annual progress reports documenting advances in cancer research, pediatric cancers, and cancer disparities. The organization also operates the Project GENIE international cancer registry, the Scientist↔Survivor Program connecting researchers with patient advocates, and maintains a grants program funding cancer researchers. AACR's ecosystem includes educational workshops, the Cancer Centers Alliance collaboration, and publications including Cancer Today magazine and the Cancer Research Catalyst blog. The organization does not offer software products, SaaS platforms, or technology integrations.

Product and service3 records
1AACR Scientific Journals Portfolio
CategoryPeer-reviewed scientific publications
2AACR Annual Meeting
CategoryConferences and meetings
3AACR Specialized Conferences and Workshops
Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-06-11
Description

Since 2014, the two organizations have collaborated on gastric cancer research grants. DDF has contributed approximately $1.65 million through various grants and awards. The AACR-Debbie's Dream Foundation Innovation and Discovery Grant provides $100,000 over two years ($50,000 in 2026, $50,000 in 2027) for innovative gastric cancer research.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-04
Description

The Mark Foundation launched a coalition of leading cancer research organizations (AACR, Lustgarten Foundation, Break Through Cancer, and Tina's Wish) dedicated to early detection of deadly cancers. The coalition is investing $12 million across six collaborative research projects focused on pancreatic, ovarian, and esophageal cancers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-04
Description

Coalition partner in the $12 million early detection initiative targeting pancreatic, ovarian, and esophageal cancers. The coalition aligns strategy and pools expertise to accelerate solutions that no single organization could achieve alone.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-04
Description

Coalition partner in the $12 million early detection initiative. Part of ambitious shift in how cancer research is funded by aligning strategy and pooling expertise across organizations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-04
Description

Coalition partner in the $12 million early detection initiative focused on pancreatic, ovarian, and esophageal cancers. These cancers often grow silently and contribute to persistently poor long-term survival rates.

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2025-12-03
Description

AWS awarded AACR an Imagine Grant worth up to $150,000 to support Project GENIE, the international cancer registry. This funding supports the publicly accessible registry assembled through data sharing between leading cancer centers worldwide.

7AACR Cancer Centers Alliance
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The AACR Cancer Centers Alliance facilitates collaboration among the nation's cancer centers on shared goals. The alliance has 94 member cancer centers working together on research coordination and advocacy.

aacr.org
Strategic tierMajorTypeGTM or Marketing Partner
Description

Pfizer provides generous support for the Patient Advocate Partners Pavilion at the AACR Annual Meeting, creating a vibrant hub for 30 patient advocacy organizations.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Co-host of the San Antonio Breast Cancer Symposium with AACR. The symposium drew more than 11,000 attendees from 104 countries and generated $39.6 million in economic impact in 2025.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

AACR partners with AACI for annual Hill Day events to advocate for NIH funding. The two organizations work together on congressional advocacy for cancer research funding.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Cancer Vaccine Coalition, founded by patient advocate Kristen Dahlgren, works to fund the next generation of cancer treatments. Dahlgren serves on the AACR Annual Meeting 2026 Program Committee.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Anjee Davis, President of Fight Colorectal Cancer, serves as member of the AACR Annual Meeting 2026 Program Committee, demonstrating collaborative engagement with advocacy organizations.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

ASCO is the leading U.S. professional society for oncologists and cancer care professionals; it operates a parallel model of journals (JCO), a major annual meeting, member dues, and advocacy programs, making it AACR's closest direct peer in membership-based cancer research.

TypeDirect peer
Description

ACS is a peer nonprofit health organization with a similar mission of advancing cancer outcomes through research funding, patient support, and advocacy. It shares AACR's donor/research-grant revenue model but operates with broader public health and patient-services scope.

TypeDirect peer
Description

CRI is a peer nonprofit focused on cancer immunology research funding and scientific convening, operating with a similar grantmaking and conference model to AACR but with a narrower immunotherapy and tumor immunology focus.

TypeRegional player
Description

ESMO is the leading European peer to AACR, running a comparable model of journals (Annals of Oncology), the annual ESMO Congress, and member-driven oncology research advocacy. It is geographically distinct but offers directly overlapping membership and meeting competition.

TypeDirect peer
Description

The V Foundation is a peer nonprofit that funds cancer research through competitive grants and partners with AACR on administering research awards, sharing AACR's nonprofit cancer-research funding and stewardship model.

TypeDirect peer
Description

Stand Up To Cancer is a peer nonprofit that raises and deploys funds for collaborative cancer research teams, often partnering with AACR on grant administration; it overlaps AACR's research-funding intermediary role.

TypeBroad incumbent
Description

NCI is the federal government's primary agency for cancer research and training. Although it is a governmental, not membership-based, organization, NCI defines the funding landscape AACR's members and grant programs depend on, making it the dominant incumbent stakeholder in AACR's ecosystem.

TypeDirect peer
Description

Damon Runyon is a peer nonprofit that funds early-career cancer researchers through fellowship and award programs. It shares AACR's research-grant funding model and career-development mission.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

American Association for Cancer Research

Professional Cancer Research Associationaacr.org

The American Association for Cancer Research (AACR) is a Philadelphia-based 501(c)(3) nonprofit membership organization founded in 1907 that serves over 65,000 cancer researchers, clinicians, and patient advocates worldwide through scientific journals, the AACR Annual Meeting, research grants, policy advocacy, and Project GENIE.

What American Association for Cancer Research does

The American Association for Cancer Research (AACR) is a 501(c)(3) nonprofit professional membership organization founded in 1907 and headquartered in Philadelphia, Pennsylvania. It is the first and largest professional organization dedicated to preventing and curing cancer through research, education, communication, and collaboration, and it currently serves more than 65,000 members worldwide, including cancer researchers, clinicians, healthcare professionals, and patient advocates. Its mission is operationalized through publications, scientific meetings, research grants, and policy advocacy.

AACR's product and technology footprint centers on a portfolio of ten peer-reviewed scientific journals (including Cancer Discovery, Cancer Research, Clinical Cancer Research, and Blood Cancer Discovery); the AACR Annual Meeting, which drew more than 22,000 attendees from over 140 countries in its 2026 edition; three annual Cancer Progress Reports covering overall, disparities, and pediatric cancer; Project GENIE, a publicly accessible international cancer registry aggregating real-world data from leading cancer centers; the Scientist↔Survivor Program connecting patient advocates with researchers; the AACR Cancer Centers Alliance of 94 member centers; and a grants program that administers fellowships, career awards, and the $15 million Trailblazer Cancer Research Grants.

AACR's business model is a diversified nonprofit funding stack: recurring annual membership dues from 65,000+ members, subscription and licensing revenue from ten scientific journals, registration fees from the Annual Meeting and specialized conferences, foundation-level philanthropic income through the AACR Foundation, and grants and donations from corporate and institutional partners such as AWS, Pfizer, Mark Foundation, Lustgarten Foundation, and Debbie's Dream Foundation. Distribution is anchored by direct member engagement, flagship and specialized conferences, peer-reviewed journals, and the Project GENIE data registry. The organization does not monetize software products, SaaS platforms, or AI model APIs.

American Association for Cancer Research firmographics

Firmographics
Name
American Association for Cancer Research
Legal name
American Association for Cancer Research
Website
https://aacr.org
Company type
Private
Founded year
1907
Operating status
Operating
Headcount range
251–500 employees
Short description
The American Association for Cancer Research (AACR) is a Philadelphia-based 501(c)(3) nonprofit membership organization founded in 1907 that serves over 65,000 cancer researchers, clinicians, and patient advocates worldwide through scientific journals, the AACR Annual Meeting, research grants, policy advocacy, and Project GENIE.
Ownership category
akta.pro rank

American Association for Cancer Research industry classification

Industry
Product category
Professional Cancer Research Association
NAICS
Voluntary Health Organizations (813212), Business Associations (813910)
SIC
Services-Membership Organizations (8600), Services-Health Services (8000)
akta.pro primary industry
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

  • Cancer research membership
  • Scientific journal publishing
  • Research conference hosting
  • Cancer research grants
  • Professional medical society

Where American Association for Cancer Research is headquartered

Location

Headquarters

HQ city
Philadelphia
HQ country
United States
HQ region
North America

Offices1 record

Markets served

American Association for Cancer Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Others, Marketing or Sales, Technology or R&D

Revenue model

  1. Membership Dues: Annual membership fees from over 65,000 members worldwide including researchers, clinicians, and patient advocates
  2. Publications and Journals: Revenue from scientific journal subscriptions and publications including Cancer Today magazine
  3. Conference and Meeting Fees: Registration fees from Annual Meeting and specialized conferences throughout the year
  4. Research Grants and Donations: Grants such as the $150,000 AWS Imagine Grant for Project GENIE, plus individual and corporate donations through AACR Foundation
  5. AACR Foundation Philanthropy: Donations, planned giving, workplace giving, and corporate partnerships supporting cancer research

Pricing tiers

ModelBillingPrice
SubscriptionOne timeReduced registration for patient advocates
SubscriptionAnnualMembership categories

Go-to-market motion2 records

Distribution channels6 records

Marketing channels9 records

American Association for Cancer Research product offering

Product offering

Core offering

AACR is a nonprofit professional membership organization that advances cancer research through membership services, a portfolio of ten peer-reviewed scientific journals, the premier global AACR Annual Meeting, specialized conferences and educational workshops, research grants and fellowships, the Project GENIE international cancer data registry, and policy advocacy. It serves more than 65,000 members worldwide, including cancer researchers, clinicians, and patient advocates, while connecting cancer centers through the AACR Cancer Centers Alliance of 94 member institutions.

Product overview

The American Association for Cancer Research (AACR) operates as a nonprofit membership organization rather than a technology product company. Its core offerings include a portfolio of 10 peer-reviewed scientific journals (Cancer Research, Cancer Discovery, Clinical Cancer Research, etc.), the AACR Annual Meeting as the premier cancer research conference, and three annual progress reports documenting advances in cancer research, pediatric cancers, and cancer disparities. The organization also operates the Project GENIE international cancer registry, the Scientist↔Survivor Program connecting researchers with patient advocates, and maintains a grants program funding cancer researchers. AACR's ecosystem includes educational workshops, the Cancer Centers Alliance collaboration, and publications including Cancer Today magazine and the Cancer Research Catalyst blog. The organization does not offer software products, SaaS platforms, or technology integrations.

Differentiator

Problem solved

Functional benefit

Products and services

  • AACR Scientific Journals Portfolio
  • AACR Annual Meeting
  • AACR Specialized Conferences and Workshops

Quantifiable outcome

  • 34% decrease in overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
  • +4 more outcomes

Companies that use American Association for Cancer Research

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

American Association for Cancer Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

American Association for Cancer Research partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered major, core and minor.

  • Debbie's Dream Foundation: Curing Stomach CancermajorStrategic or Co-development Partner · 11 June 2026Since 2014, the two organizations have collaborated on gastric cancer research grants. DDF has contributed approximately $1.65 million through various grants and awards. The AACR-Debbie's Dream Foundation Innovation and Discovery Grant provides $100,000 over two years ($50,000 in 2026, $50,000 in 2027) for innovative gastric cancer research.
  • Mark Foundation for Cancer ResearchcoreStrategic or Co-development Partner · 4 February 2026The Mark Foundation launched a coalition of leading cancer research organizations (AACR, Lustgarten Foundation, Break Through Cancer, and Tina's Wish) dedicated to early detection of deadly cancers. The coalition is investing $12 million across six collaborative research projects focused on pancreatic, ovarian, and esophageal cancers.
  • Lustgarten FoundationcoreStrategic or Co-development Partner · 4 February 2026Coalition partner in the $12 million early detection initiative targeting pancreatic, ovarian, and esophageal cancers. The coalition aligns strategy and pools expertise to accelerate solutions that no single organization could achieve alone.
  • Break Through CancercoreStrategic or Co-development Partner · 4 February 2026Coalition partner in the $12 million early detection initiative. Part of ambitious shift in how cancer research is funded by aligning strategy and pooling expertise across organizations.
  • Tina's WishcoreStrategic or Co-development Partner · 4 February 2026Coalition partner in the $12 million early detection initiative focused on pancreatic, ovarian, and esophageal cancers. These cancers often grow silently and contribute to persistently poor long-term survival rates.
  • Amazon Web Services (AWS)majorTechnology or Integration · 3 December 2025AWS awarded AACR an Imagine Grant worth up to $150,000 to support Project GENIE, the international cancer registry. This funding supports the publicly accessible registry assembled through data sharing between leading cancer centers worldwide.
  • AACR Cancer Centers AlliancecoreStrategic or Co-development PartnerThe AACR Cancer Centers Alliance facilitates collaboration among the nation's cancer centers on shared goals. The alliance has 94 member cancer centers working together on research coordination and advocacy.
  • PfizermajorGTM or Marketing PartnerPfizer provides generous support for the Patient Advocate Partners Pavilion at the AACR Annual Meeting, creating a vibrant hub for 30 patient advocacy organizations.
  • UT Health San Antonio's Mays Cancer CentermajorStrategic or Co-development PartnerCo-host of the San Antonio Breast Cancer Symposium with AACR. The symposium drew more than 11,000 attendees from 104 countries and generated $39.6 million in economic impact in 2025.
  • Association of American Cancer Institutes (AACI)majorStrategic or Co-development PartnerAACR partners with AACI for annual Hill Day events to advocate for NIH funding. The two organizations work together on congressional advocacy for cancer research funding.
  • Cancer Vaccine CoalitionminorStrategic or Co-development PartnerCancer Vaccine Coalition, founded by patient advocate Kristen Dahlgren, works to fund the next generation of cancer treatments. Dahlgren serves on the AACR Annual Meeting 2026 Program Committee.
  • Fight Colorectal CancerminorStrategic or Co-development PartnerAnjee Davis, President of Fight Colorectal Cancer, serves as member of the AACR Annual Meeting 2026 Program Committee, demonstrating collaborative engagement with advocacy organizations.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

American Association for Cancer Research competitors and assessment

Company assessment

Direct peers

  • American Society of Clinical Oncology (ASCO): ASCO is the leading U.S. professional society for oncologists and cancer care professionals; it operates a parallel model of journals (JCO), a major annual meeting, member dues, and advocacy programs, making it AACR's closest direct peer in membership-based cancer research.
  • American Cancer Society (ACS): ACS is a peer nonprofit health organization with a similar mission of advancing cancer outcomes through research funding, patient support, and advocacy. It shares AACR's donor/research-grant revenue model but operates with broader public health and patient-services scope.
  • Cancer Research Institute (CRI): CRI is a peer nonprofit focused on cancer immunology research funding and scientific convening, operating with a similar grantmaking and conference model to AACR but with a narrower immunotherapy and tumor immunology focus.
  • V Foundation for Cancer Research: The V Foundation is a peer nonprofit that funds cancer research through competitive grants and partners with AACR on administering research awards, sharing AACR's nonprofit cancer-research funding and stewardship model.
  • Stand Up To Cancer: Stand Up To Cancer is a peer nonprofit that raises and deploys funds for collaborative cancer research teams, often partnering with AACR on grant administration; it overlaps AACR's research-funding intermediary role.
  • Damon Runyon Cancer Research Foundation: Damon Runyon is a peer nonprofit that funds early-career cancer researchers through fellowship and award programs. It shares AACR's research-grant funding model and career-development mission.

Regional players

  • European Society for Medical Oncology (ESMO): ESMO is the leading European peer to AACR, running a comparable model of journals (Annals of Oncology), the annual ESMO Congress, and member-driven oncology research advocacy. It is geographically distinct but offers directly overlapping membership and meeting competition.

Broad incumbents

  • National Cancer Institute (NCI): NCI is the federal government's primary agency for cancer research and training. Although it is a governmental, not membership-based, organization, NCI defines the funding landscape AACR's members and grant programs depend on, making it the dominant incumbent stakeholder in AACR's ecosystem.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

American Association for Cancer Research social profiles

Digital presence

American Association for Cancer Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

American Association for Cancer Research leadership team

Management profile

Number of profiles

Profiles4 records

American Association for Cancer Research funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

American Association for Cancer Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Association for Cancer Research

What does American Association for Cancer Research do?

AACR is a nonprofit professional membership organization that advances cancer research through membership services, a portfolio of ten peer-reviewed scientific journals, the premier global AACR Annual Meeting, specialized conferences and educational workshops, research grants and fellowships, the Project GENIE international cancer data registry, and policy advocacy. It serves more than 65,000 members worldwide, including cancer researchers, clinicians, and patient advocates, while connecting cancer centers through the AACR Cancer Centers Alliance of 94 member institutions.

Is American Association for Cancer Research a public or private company?

American Association for Cancer Research is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was American Association for Cancer Research founded?

American Association for Cancer Research was founded in 1907. It employs 251 to 500 people.

Where is American Association for Cancer Research based?

American Association for Cancer Research is headquartered in Philadelphia, United States, in the North America region.

How does American Association for Cancer Research make money?

Five revenue lines are on record. Membership Dues are the primary driver. The others are publications and Journals, conference and Meeting Fees, research Grants and Donations and AACR Foundation Philanthropy.

Who are American Association for Cancer Research's main competitors?

Direct peers on record are American Society of Clinical Oncology (ASCO), American Cancer Society (ACS), Cancer Research Institute (CRI), V Foundation for Cancer Research, Stand Up To Cancer and Damon Runyon Cancer Research Foundation. European Society for Medical Oncology (ESMO) is listed as a regional player. National Cancer Institute (NCI) is listed as a broad incumbent.

Does American Association for Cancer Research have an API?

No public API is recorded for American Association for Cancer Research.

What industry is American Association for Cancer Research in?

American Association for Cancer Research's product category is Professional Cancer Research Association. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NatureThe top cancer success stories of the past 50 years, by the numbersA report by the American Association for Cancer Research found 71% of US cancer patients live at least five years after diagnosis, up from 49% in the late 1970s. Lung cancer five-year survival rose from 13% to 29% between 1975-1979 and 2016-2022, and childhood lymphoid leukaemia survival increased from 57% to 90%.TODAY.comAmanda Peet on ‘Your Friends & Neighbors,’ Family, Cancer BattleAmanda Peet joins TODAY's Jenna Bush Hager and Sheinelle Jones to discuss Season Three of 'Your Friends & Neighbors,' her celebrity crush, slang from her kids, and parenting teens. Dr. Keith Flaherty, president of the American Association for Cancer Research, joins to discuss her breast cancer experience and research advancements.New York PostGLP-1 drugs could play surprising role in cancer risk and outcomesThe American Association for Cancer Research's 2026 report notes mixed evidence on GLP-1 drugs' cancer risk, with no randomized trials yet. A doctor cited lower recurrence rates in patients on GLP-1s, but some studies showed increased thyroid cancer risk. Future trials may clarify if benefits depend on weight loss.YahooPopular weight-loss drugs may play surprising role in cancer outcomesGLP-1 weight-loss drugs like Ozempic and Wegovy are being studied for cancer risk and outcomes, with some studies suggesting reduced cancer risk and higher survival. The American Association for Cancer Research's 2026 report notes mixed evidence and a need for randomized trials. A doctor suggests future trials may show benefits depend on weight loss.AJMCFrom “Super Skeptical” Beginnings, a New Immune-Modulatory Vaccine Awaits Phase 3 ResultsIO Biotech presented new preclinical data at the American Association for Cancer Research demonstrating that its immune-modulatory cancer vaccines, specifically IO102/IO103 and IO170, effectively activate T cells to reprogram the tumor microenvironment. The company is currently conducting a phase 3 trial for metastatic melanoma with results expected in Q3 2025, while also completing enrollment in a phase 2 basket trial for melanoma and head and neck cancers. These developments support IO Biotech's goal to file a Biologics License Application with the FDA by the end of 2025.Fox NewsViagra could do more than advertised as study reveals surprising health superpowerNew research published by the American Association for Cancer Research found that sildenafil, the active ingredient in Viagra manufactured by Viatris, may restrict cancer metastasis by limiting cancer cells' ability to use cholesterol. Researchers at the Weizmann Institute of Science in Israel, in collaboration with the U.S. National Cancer Institute, analyzed human and mouse cancer cells and 20 years of health data from five million members of Clalit Health Services. The researchers suggested that combining Viagra-related drugs with statins could help slow cancer spread, though they acknowledged limitations including that mouse model findings may not translate to humans and the human evidence is observational rather than proving causation.NPRCancer disparities researchers say federal funding changes have disrupted their workFederal funding changes under the Trump administration have significantly disrupted cancer disparities research, with 93% of surveyed researchers in the field reporting being affected, according to a report by the American Association for Cancer Research. The report documents that 181 National Cancer Institute grants totaling over $317 million were canceled in roughly the first half of 2025, following an executive order targeting certain DEI-related research. Researchers describe having to lay off staff, reframe projects to maintain compliance, and warn that the disruption threatens progress in closing cancer outcome gaps that currently cost American society approximately $451 billion annually.MarketScreenerUS schools, research advocates urge withdrawal of proposed rule on federal grantsTop U.S. universities and research advocacy groups, including Johns Hopkins University, Georgetown University, and the American Association for Cancer Research, urged President Trump's administration on July 13 to withdraw a proposed rule that would revise the government's "Uniform Guidance" for federal financial assistance. The May 29 notice of proposed rulemaking from the White House Office of Management and Budget would authorize agencies to unilaterally modify or terminate awards based on shifting policy priorities while eliminating existing appeals processes. Critics warn the changes would shift grant decisions from merit to politics, destabilize the nation's innovation ecosystem, and severely set back medical science and research outcomes.UsnewsRacial Gaps Narrow For U.S. Cancer Deaths, Report FindsThe American Association for Cancer Research released its Cancer Disparities Progress Report 2026, showing that racial disparities in cancer death rates among U.S. patients have narrowed substantially, with the gap between Black and white Americans dropping from 34% higher in 1991 to 9% in 2024. The overall U.S. cancer death rate has fallen 35% since 1991, preventing more than 4.8 million deaths and resulting in over 18.6 million cancer survivors. Despite this progress, Black people and American Indians/Alaska natives continue to experience the highest overall cancer death rates, and researchers note that geographic, economic, and gender identity-based disparities in cancer outcomes remain significant.Mirage NewsAACR Unveils 2026 Cancer Disparities ReportThe American Association for Cancer Research (AACR) released its Cancer Disparities Progress Report 2026, a comprehensive biennial analysis examining the unequal burden of cancer across the United States. First published in 2020, the report documents progress against cancer disparities while highlighting the disproportionate toll cancer continues to exact on racial and ethnic minority groups, sexual and gender minorities, rural residents, and persistent-poverty regions. The AACR is calling for continued federal support for cancer disparities research to ensure advances benefit all patients regardless of background.